Investor profile
Lexham Partners
See how your deck fits this investor's thesis, stage, and ticket size.
Analyse your fitInvestment thesis
Lexham Partners invests in companies that will shape tomorrow's world, partnering with world-class investors to back and build next-generation companies founded by bold and brilliant entrepreneurs. The firm employs two distinct investment strategies: a seed-stage fund targeting HealthTech and Life Sciences startups in the UK, emphasizing early-stage investments in innovative companies at the forefront of healthcare technology; and a $200 million growth fund focused on the MENA region, seeking to capitalize on growth opportunities in technology companies aligned with the region's digital transformation agenda, particularly Saudi Arabia's Vision 2030. Lexham looks for bold entrepreneurs leading innovative companies with strong fundamentals, scalable platforms, and significant impact potential across healthcare, biotech, fintech, deeptech, and cleantech sectors.
Notable quotes
“Lexham is delighted to become shareholders alongside IP Group in some of the most exciting British innovation companies. We look forward to deepening our partnership with IP Group and supporting the portfolio companies to fulfil their growth potential.”
Recent investments
| Company | Round | Size | Date |
|---|---|---|---|
| Qured | Seed | $5m | 2025-08-13 |
| Habitual | Seed | $2m | 2025-04-14 |
| Paragraf | Series C | $55m | 2024-09 |
| Oxford Nanopore Technologies | Secondary | — | 2024-12 |
| Bramble Energy | Secondary | — | 2024-12 |
| Nexeon | Secondary | — | 2024-12 |
| Oxa | Secondary | — | 2024-12 |
| Tissue Regenix | Secondary | — | 2024-12 |
| AllergyRhino | Seed | — | 2024 |
Frequent co-investors
| VC firm | Deals together |
|---|---|
| IP Group | 6 |
| Mubadala Capital | 2 |
| Molten Ventures | 2 |
| Araya Ventures | 1 |
Fit check
Is Lexham Partners a match for your startup?
Upload your deck and get an instant AI-powered fit analysis — see exactly how your startup aligns with this investor's thesis, stage focus, and ticket size.
Analyse your fit